A. Siever

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Margaret Burnett, Gavin Giovannoni, 2018, The Lancet.

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse, A. Verier, M. Valis, 2018, Multiple sclerosis and related disorders.

Specific antigen binding by activated cerebrospinal fluid B lymphocytes in acute neuroborreliosis

W. Beuche, K. Felgenhauer, A. Siever, 1992, Journal of Neurology.

Quality of life in 1000 patients with early relapsing–remitting multiple sclerosis

J. Fischer, N. Putzki, H. Hartung, 2009, European journal of neurology.

Electromyography of the serratus anterior and subscapularis muscles: description of a technique.

C. Reimers, A. Siever, M. Kunkel, 1996, Journal of neurology, neurosurgery, and psychiatry.

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study

L. Kappos, G. Comi, R. Gold, 2013, Journal of Neurology.